The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria.

@article{Nordmann2009TheRT,
  title={The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria.},
  author={Patrice Nordmann and Gaelle Cuzon and Thierry Naas},
  journal={The Lancet. Infectious diseases},
  year={2009},
  volume={9 4},
  pages={
          228-36
        }
}

Figures from this paper

Emergence of Klebsiella pneumoniae Carbapenemase-Producing Bacteria
TLDR
The purpose of this review is to identify the various challenges that KPC-producing bacteria present to clinicians, including the need for special techniques for microbiological detection, the potential for nosocomial transmission, and therapeutic challenges related to limited, relatively unproven antimicrobial treatment options.
The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide.
  • P. Nordmann, L. Poirel
  • Biology, Medicine
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
  • 2014
TLDR
Control of the spread of carbapenemase producers in Enterobacteriaceae is still possible in hospital settings, and relies on the use of rapid diagnostic techniques and the strict implemention of hygiene measures.
KPC-Producing Klebsiella pneumoniae Strains : A Threat to our Therapeutic Arsenal
TLDR
The detection of KPC-2-producing K. pneumoniae strains belonging to CC11 in urban rivers is epidemiological evidence demonstrating that the environmental dissemination of high-risk multiresistant bacteria is ongoing in Brazil and other countries.
First Report of Klebsiella pneumoniae-Carbapenemase-3-Producing Escherichia coli ST479 in Poland
TLDR
The ability of E. coli to produce carbapenemase enzymes is described based on the results of the combination disc assay with boronic acid performed according to guidelines established by the European Community on Antimicrobial Susceptibility Testing (EUCAST) and the biochemical Carba NP test.
Evaluation of Boronic Acid Disk for Detection of Klebsiella pneumoniae Carbapenemase in Klebsiella pneumoniae
TLDR
A limited number of antimicrobials are available for treatment of KPC infections with a high rate of therapeutic failure and at least 50% mortality rates (Lee and Burgess, 2012).
Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts.
  • H. Grundmann, D. Livermore, Y. Carmeli
  • Biology, Medicine
    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
  • 2010
TLDR
A consultation of experts from 31 countries set out to identify the gaps in diagnostic and response capacity, to index the magnitude of carbapenem-non-susceptibility across Europe using a novel five-level staging system, and to provide elements of a strategy to combat this public health issue in a concerted manner.
Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance
TLDR
It seems that ST258 is a hybrid clone that was created by a large recombination event between ST11 and ST442, and incompatibility group F plasmids with blaKPC have contributed significantly to the success of ST258.
[Carbapenemases in enterobacteriaceae].
  • P. Nordmann, A. Carrer
  • Biology, Medicine
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie
  • 2010
NARA CPE Guidelines
TLDR
Rapid and accurate detection of carbapenemase-producing Enterobacteriales (CPE) is becoming fundamental to any strategy aiming at controlling their diffusion as well as for guiding the antibiotherapy.
A carbapenem-resistant Klebsiella pneumoniae isolate harboring KPC-1 from Italy.
TLDR
The frequency of carbapenemases producing Klebsiella pneumoniae is increasing in different geographic regions: the majority of isolates has been collected in the USA, but recently KPC-producing K. pneumoniae were reported from China, Israel, Greece, France, Norway and Sweden.
...
...

References

SHOWING 1-10 OF 92 REFERENCES
Plasmid-Mediated Carbapenem-Hydrolyzing β-Lactamase KPC-2 in Klebsiella pneumoniae Isolate from Greece
TLDR
A K. pneumoniae isolate from Greece that produced β-lactamase KPC-2 is reported, which was resistant to all antibiotics except gentamicin according to disk diffusion susceptibility testing results and showed significant carbapenem hydrolyzing activity.
Evaluation of Techniques for Detection of Carbapenem-Resistant Klebsiella pneumoniae in Stool Surveillance Cultures
TLDR
The method of placing a sample from a fecal surveillance culture into broth containing an imipenem disk appeared to have the greatest sensitivity for detecting KPC-producing K. pneumoniae.
Carbapenem-hydrolysing beta-lactamase KPC-2 in Klebsiella pneumoniae isolated in Rio de Janeiro, Brazil.
TLDR
These findings should alert medical authorities to implement stringent methods for the detection and spread control of emerging KPC-2 carbapenemases in the hospital setting in Brazil.
Evaluation of Methods To Identify the Klebsiella pneumoniae Carbapenemase in Enterobacteriaceae
TLDR
Ertapenem was a more sensitive indicator of KPC resistance than meropenem and imipenem independently of the method used and Carbapenemase production could be confirmed with the modified Hodge test.
Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom.
TLDR
The first KPC-3-producing K. pneumoniae isolates detected in the UK were highly genetically related to a K PC-3 thematic strain characterized previously in Tel Aviv, Israel, consistent with the history of one UK patient, who had been hospitalized previously in Israel.
Plasmid-mediated, carbapenem-hydrolysing beta-lactamase, KPC-2, in Klebsiella pneumoniae isolates.
TLDR
Four isolates of Klebsiella pneumoniae obtained from patients at a Maryland medical centre exhibited reduced susceptibility to carbapenems and were found to produce the novel, class A, plasmid-mediated,carbapenem-hydrolysing enzyme, KPC-2, which was associated with positive extended-spectrum beta-lactamase (ESBL) confirmation tests.
Identification of carbapenem-resistant klebsiella pneumoniae harboring KPC enzymes in New Jersey.
TLDR
The clinical characteristics and molecular epidemiology associated with 12 randomly chosen patients in whom carbapenem-resistant K. pneumoniae isolates harboring KPC beta-lactamases were detected by molecular methods at the Veterans Administration Hospital in New Jersey are described.
Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium.
TLDR
Carapenem-resistant K pneumoniae isolates are rapidly emerging in New York City and automated systems used for susceptibility testing may not accurately identify all these isolates, which will severely hamper control efforts.
Plasmid-mediated carbapenem-hydrolysing beta-lactamase KPC-2 in carbapenem-resistant Serratia marcescens isolates from Hangzhou, China.
TLDR
This is the first report of detection of a plasmid-encoded carbapenem-hydrolysing enzyme KPC-2 in S. marcescens, and it is suggested that this strain is susceptible to all antibiotics except ampicillin.
...
...